FTDP-17 without parkinsonism in family with the tau gene (MAPT) mutation

被引：0
|
作者：
Chodakowska-Zebrowska, Malgorzata [1 ]
Barczak, Anna [1 ]
Berdynski, Mariusz [2 ]
Sikorska, Jolanta [1 ]
Barcikowska, Maria [2 ]
机构：
[1] CSK MSWiA Hosp, Warsaw, Poland
[2] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland
来源：
PHARMACOLOGICAL REPORTS | 2009年 / 61卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1225 / 1225
页数：1
相关论文
共 50 条
  • [21] Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation
    Lindquist, S. G.
    Holm, I. E.
    Schwartz, M.
    Law, I.
    Stokholm, J.
    Batbayli, M.
    Waldemar, G.
    Nielsen, J. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (04) : 377 - 385
  • [22] Hippocampal pathology in patients with FTDP-17 and a mutation in the intron following exon 10 (+16) of the Tau gene.
    Miravalle, L
    Murrell, JR
    Takao, M
    Richardson, R
    Bassett, SS
    Crain, B
    Ghetti, B
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 548 - 548
  • [23] FTDP-17与Tau基因突变
    汪青
    朱粹青
    国外医学(老年医学分册), 1999, (06) : 241 - 243
  • [24] Influence of FTDP-17 mutants on circular tau RNAs
    Margvelani, Giorgi
    Welden, Justin R.
    Maquera, Andrea Arizaca
    Van Eyk, Jennifer E.
    Murray, Christopher
    Sardon, Sandra C. Miranda
    Stamm, Stefan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (04):
  • [25] The effect of tau genotype on clinical features in FTDP-17
    Baba, Y
    Tsuboi, Y
    Baker, MC
    Uitti, RJ
    Hutton, ML
    Dickson, DW
    Farrer, M
    Putzke, JD
    Woodruff, BK
    Ghetti, B
    Murrell, JR
    Boeve, BF
    Petersen, RC
    Verpillat, P
    Brice, A
    Delisle, MB
    Rascol, O
    Arima, K
    Dysken, MW
    Yasuda, M
    Kobayashi, T
    Sunohara, N
    Komure, O
    Kuno, S
    Sperfeld, AD
    Stoppe, G
    Kohlhase, E
    Pickering-Brown, S
    Neary, D
    Bugiani, O
    Wszolek, ZK
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) : 205 - 208
  • [26] INTER- AND INTRAFAMILIAL CLINICAL HETEROGENEITY IN FTDP-17 ASSOCIATED WITH MAPT 10+16 MUTATION
    Larner, A. J.
    Doran, M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [27] Diffuse loss of myelin in FTDP-17 associated with mutation N279k in the Tau gene.
    Ghetti, B
    Dickson, D
    Rascol, O
    Tsuboi, Y
    Murrell, JR
    Wszolek, Z
    Delisle, MB
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (05): : 583 - 583
  • [28] Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17
    Yen, SH
    Hutton, M
    DeTure, M
    Ko, LW
    Nacharaju, P
    BRAIN PATHOLOGY, 1999, 9 (04) : 695 - 705
  • [29] Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation)
    Arvanitakis, Zoe
    Witte, Robert J.
    Dickson, Dennis W.
    Tsuboi, Yoshio
    Uitti, Ryan J.
    Slowinski, Jerzy
    Hutton, Michael L.
    Lin, Siong-Chi
    Boeve, Bradley F.
    Cheshire, William P.
    Pooley, Robert A.
    Liss, Julie M.
    Caviness, John N.
    Strongosky, Audrey J.
    Wszolek, Zbigniew K.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 (04) : 230 - 239
  • [30] FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation
    Sperfeld, AD
    Collatz, MB
    Baier, H
    Palmbach, M
    Storch, A
    Schwarz, J
    Tatsch, K
    Reske, S
    Joosse, M
    Heutink, P
    Ludolph, AC
    ANNALS OF NEUROLOGY, 1999, 46 (05) : 708 - 715
12345